Compare COCP & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COCP | MXC |
|---|---|---|
| Founded | 2006 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6M | 17.6M |
| IPO Year | 2011 | 1995 |
| Metric | COCP | MXC |
|---|---|---|
| Price | $1.18 | $11.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 54.9K | ★ 81.0K |
| Earning Date | 05-15-2026 | 02-10-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | ★ 54.65 | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | ★ $12,712,091.00 | $2,705,235.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $45.25 |
| Revenue Growth | N/A | ★ 7.12 |
| 52 Week Low | $0.76 | $7.16 |
| 52 Week High | $2.03 | $16.48 |
| Indicator | COCP | MXC |
|---|---|---|
| Relative Strength Index (RSI) | 55.04 | 61.34 |
| Support Level | $0.91 | $8.68 |
| Resistance Level | $1.22 | $11.81 |
| Average True Range (ATR) | 0.07 | 0.65 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 36.84 | 82.59 |
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
Mexco Energy Corporation is an independent oil and gas company. It is engaged in the acquisition, exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.